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German traveller to Thailand
Jonas Ehrhardt1, Andreas Trein2, Peter Gottfried Kremsner1 and Matthias Frank1*Abstract
A case of Plasmodium knowlesi and HIV co-infection is reported in a German traveller returning from Thailand. The
54 year-old patient presented to the Institute of Tropical Medicine in Tübingen with a 11-day history of daily fever and
chills. Initial microscopic evaluation of Giemsa-stained thin blood smears was suggestive of a mixed infection with
Plasmodium falciparum and Plasmodium malariae. However, PCR amplification of small subunit ribosomal RNA gene
revealed a P. knowlesi infection. Parasitaemia was 473 parasites/μl and the platelet count was within the normal range.
Oral treatment with Malarone® was initiated and resulted in a fast recovery without any complications.
As part of routine screening the patient also underwent HIV testing and was found to be HIV positive with a CD4 cell
count of 115/μl and a viral load of 34,799 copies/ml. A follow-up measurement of the viral load seven days after the first
quantification revealed an increase to 102,000 copies/ml. Three months after the first quantification the viral load had
dropped to 10,000 copies/ml without the initiation of antiretroviral treatment. This suggests the possibility of a P. knowlesi
malaria-induced temporary elevation of viral load similar to that reported for P. falciparum and HIV co-infection.
Keywords: Plasmodium knowlesi, Traveller, Thailand, Plasmodium knowlesi HIV co-infection, Viral load, Malaria, Malarone®,
SeverityBackground
In the last eight years a growing body of literature con-
firmed the existence of a fifth species of Plasmodium cap-
able of causing human malaria. The fifth species is
Plasmodium knowlesi, a malaria parasite naturally circulat-
ing in long-tailed (Macaca fascicularis) and pig-tailed
(Macaca nemestrina) macaques in Southeast Asia. In
2004, Singh and colleagues described the first large focus
of naturally acquired P. knowlesi infections in humans in
the Kapit division of Sarawak (Malaysian Borneo) [1].
Thereafter, numerous reports followed and confirmed
the existence of human P. knowlesi infections throughout
Malaysian Borneo [2-5] and Peninsular Malaysia [2,6], as
well as nearly every country in Southeast Asia (Myanmar
[7], Vietnam [8], Philippines [9], Thailand [10], Cambodia
[11], Singapore [12]). The frequency of P. knowlesi in
patients with microscopically diagnosed malaria ranges
from less than 1% (e g, in Thailand) [10] to up to 60%
(Malaysian Borneo) [5]. Since 2004, twelve cases of* Correspondence: matthias.frank@uni-tuebingen.de
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reproduction in any medium, provided the orimported P. knowlesi malaria to non-endemic countries
have been published [13-24]. Eleven cases developed un-
complicated malaria and were successfully treated with
common anti-malarial drugs, one patient improved
spontaneously (without receiving treatment) [22]. How-
ever, lethal outcomes due to P. knowlesi malaria have been
described in Southeast Asia. Case-fatality rates of 2% (dis-
trict hospital) [25] and 11% (referral hospital) [26] have
been reported. No deaths occured in a recent prospective
study in a referral hospital in Malaysian Borneo, where se-
vere P. knowlesi cases were treated with oral artesunate
combination therapy or intravenous artesunate [27].
It has been reported that HIV infection increases the
susceptibility to malaria [28,29] and the risk of developing
severe Plasmodium falciparum malaria [30-33]. At the
same time P. falciparum malaria causes a transient eleva-
tion of viral load in HIV-positive individuals [34-36]. The
interactions between malaria and HIV have been studied
mainly in African countries with P. falciparum-infected
patients. There is currently no published information
about P. knowlesi malaria and HIV co-infection available.
This is the first description of P. knowlesi malaria in an
HIV-positive adult with advanced immunosuppression.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A 54 year-old German traveller presented to the Institute
of Tropical Medicine in Tübingen with fever, chills and se-
vere headaches. Twenty days prior to presentation the pa-
tient had returned from a four-week trip to southern
Thailand where he visited with his Thai wife. He stayed
nearly all the time in Phuket and never took malaria
chemoprophylaxis (please see below for a more detailed
description of the trip). Eleven days prior to presentation
the symptoms started with a sudden onset of fever (initially
up to 40°C) and chills. Thereafter fever decreased grad-
ually, but the patient continued to experience low grade fe-
vers around 38.5°C until the day of presentation. Eight
days prior to presentation the patient noticed a temporary
rash on the lower limbs that he related to the intermittent
use of Paracetamol. On examination, the patient was in no
acute distress but appeared fatigued. The temperature was
37.4°C and vital signs were stable (blood pressure 120/
75 mmHg, heart rate of 86 beats per minute). With the ex-
ception of tenderness in the left upper abdominal quadrant
the physical examination was unremarkable. Abdominal
ultrasound revealed mild splenomegaly (14.1 × 6.2 cm).
Laboratory tests showed mild anaemia (haemoglobin
12.5 g/dl, normal 14–18 g/dl), elevation of lactate dehydro-
genase (351 U/l, normal <251 U/l) and C-reactive protein
(2.39 mg/dl, normal <0.51 mg/dl). Values were normal for
platelet count (197,000/μl, normal 150,000 – 400,000/μl),
white cell count (4.100/μl, normal 4,000 – 9,500/μl), total
bilirubin (0.8 mg/dl, normal <1,2 mg/dl) and plasma cre-
atinine (0.9 mg/dl, normal 0.6 – 1.1 mg/dl). Rapid diagnos-
tic tests for dengue were negative (Dengue Dx IgG/IgMFigure 1 Giemsa-stained thin blood smears with Plasmodium knowles
display ring stage parasites. Panel C shows a band-form. Panels D and E shand NS1 Antigen Rapid Test, Focus Diagnostics, USA).
Giemsa-stained thick and thin blood smears showed
the presence of malaria parasites (Figure 1). Using the
Lambaréné method parasitaemia was estimated to be
about 0.01% (473 parasites/μl). Microscopic evaluation of
thin blood smears revealed several ring stage parasites with
a morphology reminiscent of P. falciparum ring stage para-
sites. However, several late trophozoite stage parasites with
haemozoin pigment as well as gametocytes with a size of
an uninfected red blood cell were identified. Based on
these morphologic features the presumptive diagnosis of a
co-infection with P. falciparum and Plasmodium malariae
was made. Treatment with atovaquone/proguanil 250 mg/
100 mg (four tablets/day for three days) was initiated and
the patient was admitted to the hospital. During anti-
malarial therapy the parasitaemia cleared rapidly. Serial
blood smears revealed a parasitaemia of 70/μl after 24 hours
and 11/μl after 48 hours of therapy. The platelet count after
24 hours and 48 hours of therapy was 249.000/μl and
257.000 μl respectively.
Due to the uncertain blood smear identification of Plas-
modium species, small subunit ribosomal RNA gene PCR
amplification was performed. The PCR fragment was se-
quenced and a BLAST search in the GenBank database
(basic local alignment search tool) showed a 96%-match
with P. knowlesi sequences. No other human plasmodial
species were identified by the BLAST search. The patient
was discharged after three days in improved conditions.
In addition, at day of presentation HIV testing was
performed as part of routine screening. The patient’s last
testing dated four years back and had been negative.i parasites (magnification: 100×, oil immersion). Panels A and B
ow late trophozoite parasites. Panel F displays a gametocyte.
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firmed by Western blot. The CD4 cell count was 115/μl
and viral load was 34,799 copies/ml. On repeated
questioning the patient reported that the relationship
with his Thai wife started four years ago. At that point
both partners underwent HIV testing and were found to
be HIV negative. During the patient’s yearly visits to
Thailand the couple had unprotected intercourse. The
patient stated that except for his wife he had not had
any other sexual partners for the last four years. An ill-
ness suggestive of acute HIV could not be recalled.
Seven days after the day of presentation the viral load
measurement was repeated at an outside physician’s of-
fice and showed an increase to 102,000 copies/ml.
Eleven days after the day of presentation the patient
presented for a follow-up examination. The physical
examination was without pertinent positive findings.
However, the patient continued to complain about fa-
tigue and night sweats. A repeat blood smear was nega-
tive for malarial parasites. The complete blood count
revealed a white blood cell count of 3,200 cells/μl and
unchanged haemoglobin of 12.2 g/dl. The values for
lactate dehydrogenase and C-reactive protein were
within normal limits. More detailed questioning of the
travel history revealed that the patient had stayed three
weeks at his house in Phuket where he lived with his
wife. From the last week of the four-week trip he had
spend three days in Ranong Province (southern part of
the border to Myanmar). He noted that while walking
in the local forests and fishing in the Andaman Sea he
suffered a lot of mosquito bites. There was no contact
with monkeys reported. For long-term HIV care the pa-
tient was referred to a specialized HIV centre. Five
weeks after the P. knowlesi infection the viral load
follow-up revealed a drop to 17,000 copies/ml without
antiretroviral therapy. Three months after the P.
knowlesi infection, viral load was 10,000 copies/ml still
without antiretroviral therapy. The CD4 cell count was
204/μl and 264/μl respectively (Table 1).
According to official guidelines [37], the patient met
criteria for the initiation of antiretroviral therapy. The
necessity of starting antiretroviral therapy was repeatedly
discussed with the patient. However, he repeatedly
rejected this due to his personal attitude towards con-
ventional medicine and instead expressed hope of spon-
taneous improvement.Table 1 Development of the viral load and CD4 count
Day 1* Day 7 Day 37 Day 87
(week 5) (week 12)
Viral load (copies/μl) 34 799 102 000 17 000 10 000
CD4 count (cells/μl) 115 223 204 264
*Day of presentation of the patient with acute P. knowlesi malaria.Conclusions
Plasmodium knowlesi cases have been detected in several
regions of Thailand mainly in forestal areas bordering
Cambodia in the east, Malaysia in the south and Myanmar
in the north-west [10]. A recent study confirmed the
transmission of P. knowlesi in Ranong Province (southern
part of the border to Myanmar) [38], where the here
presented patient stayed for three days and where he most
likely acquired the infection. The overall incidence of
P. knowlesi malaria in Thailand is low. Among 1874 febrile
patients attending malaria clinics in different areas of
Thailand the overall prevalence of P. knowlesi was 0.57%
[10]. Nevertheless, this is already the second imported
case of a travel-related P. knowlesi infection acquired in
Thailand [21]. This indicates that even short-term travel-
lers are at risk of P. knowlesi infections and that due to in-
creasing travel activities to Southeast Asia, imported
P. knowlesi malaria might become more important in
non-endemic countries.
During the initial questioning the patient stated that he
had stayed all the time of the voyage in Phuket where
Plasmodium species transmission is minimal [39] and no
cases of P. knowlesi infections have been reported. Only
on repeat questioning during the follow-up visit did the
patient recall a short visit to Ranong Province. This serves
as a reminder that malaria has to be excluded in returning
travellers from Thailand, even if they report primarily vis-
iting areas with very low incidence of malaria.
It has been shown for P. falciparum malaria that HIV-
positive individuals have a temporarily increased viral
load during acute malaria [34-36]. Kublin and colleagues
described an increase of viral load during symptomatic
malaria (median log increase of 0.42, p < 0.0001) and a
subsequent decrease of viral load back to baseline eight
weeks after anti-malarial treatment [34]. A similar obser-
vation could be made in the here presented HIV-positive
adult with acute P. knowlesi malaria. A baseline measure-
ment before the acute malaria infection was not available
as the HIV infection was diagnosed for the first time.
Nevertheless, an increase in viral load was observed
shortly after the P. knowlesi infection with a subsequent
drop at follow-up examinations five and 12 weeks later
without the initiation of antiretroviral therapy. These find-
ings suggest a possible influence of acute P. knowlesi
malaria on pre-existing HIV infection, resulting in a tem-
porary increase in viral load as it has been described for
acute P. falciparum malaria. However, as this is an obser-
vation in one patient it is necessary to assess more cases
in order to confirm this finding.
The described finding raises the question as to whether
there are other similarities between clinical characteristics
of HIV-P. falciparum co-infection and those of HIV-P.
knowlesi co-infection. Most P. knowlesi-infected individ-
uals develop clinically uncomplicated malaria, but severe
Ehrhardt et al. Malaria Journal 2013, 12:283 Page 4 of 5
http://www.malariajournal.com/content/12/1/283cases with lethal outcomes have been described recently
[2]. It has been shown for P. falciparum malaria that HIV-
positivity is a risk factor for the development of severe
malaria and death [30-33]. In a prospective cohort study
in South Africa, HIV-infected individuals with a CD4 cell
count <200/μl had an increased risk of severe malaria
(odds ratio 4.8) [30]. Two studies investigating imported
P. falciparum malaria to non-endemic countries showed
that severe malaria was more frequent in patients with a
CD4 cell count <350/μl, (odds ratio 2.5 and 3.2) [32,33].
The clinical course of the P. knowlesi malaria case de-
scribed here was uncomplicated despite marked immuno-
suppression of the patient (115 CD4 positive cells/μl).
Two research groups recently established the hight of
parasitaemia as a good predictor for the risk of severe dis-
ease (≥35,000 parasites/μl [40] and >20,000 parasites/μl
[27]). The parasitaemia observed in the here presented pa-
tient was relatively low (473 parasites/μl). Therefore the
uncomplicated course of the patients’ disease supports the
apparent correlation of height of parasitaemia and severity
of disease in P. knowlesi malaria. Anaemia was mild and
there was neither acidosis nor renal failure, which are
frequently associated with severe P. knowlesi infections
[26,40].
Interestingly, thrombocytopaenia, which is nearly uni-
versal in patients with P. knowlesi infection [25-27], was
not present. However, it is important to note that the
platelet count was at the lower limit of the normal range
on presentation and increased after the beginning of
antimalarial therapy. It has recently been published that
thrombocytopaenia in P. knowlesi malaria improves on
average 24 hours after successful parasite clearance,
suggesting a possible relation between P. knowlesi para-
sitaemia and a decreased platelet count [27]. It is there-
fore possible that the low parasitaemia of the described
patient resulted in a relative small decrease of the plate-
let count. In addition the nadir of the platelet count may
have occurred prior to presentation since the patient
only presented eleven days after the onset of symptoms.
Previous P. knowlesi cases that are published without the
development of thrombocytopaenia include a 11-year
old boy with chronic myeloid leukaemia taking imatinib
[5] and two asplenic patients [27]. Taken together those
cases suggest a possible immune-related component in
the development of thrombocytopaenia during acute
P. knowlesi malaria. It is tempting to speculate that the
HIV co-infection contributed to the absence of thrombo-
cytopaenia in the presented case, however it is not pos-
sible to address this question on the basis of a single
case report.
The current case is the first description of P. knowlesi
malaria in an HIV-positive adult with advanced im-
munosuppression. The patient experienced a temporary
elevation of the viral load that might have been due tothe acute P. knowlesi malaria. Despite advanced im-
munosuppression the patient’s laboratory parameters
were not suggestive of a severe P. knowlesi infection and
he had an uncomplicated clinical course.
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